Search results for: 'ec ai solution'

This study examines the development prospects that artificial intelligence (AI) offers the commercial vehicle (CV) industry, focusing on both the revolutionary potential of AI and the difficulties businesses face in fostering growth, including complicated regulations, high capital expenditure, and challenges in incorporating new technology into pre...

This Frost & Sullivan research service discusses advances in AI integration in Molecular Diagnostics, highlights key advantages of incorporating AI in the diagnostics workflow and roadblocks that have prevented it from becoming mainstream. While AI is widely used in radiology- and pathology-based diagnostics, its adoption is gradually increasing in...

The COVID-19 pandemic rapidly changed how buildings function. Building mobility solutions have gained more importance and will form a crucial part of buildings and cities in the near future. Rapid employment of the Internet of Things (IoT), artificial intelligence (AI), and cloud technologies will make products smarter and revolutionize mobility in...

As artificial intelligence (AI) moves from experimentation to enterprise deployment, growth is no longer limited by access to models. It is increasingly shaped by how well organizations can scale, govern, and monetize AI in real operating environments. The AI technologies and platforms market is entering a phase where economics, trust, regulation, ...

This Frost & Sullivan market insight presents an overview of the artificial intelligence (AI) initiatives powering the next-generation business support system (BSS) initiatives in the global mobile communications market. It describes the various opportunities that generative AI (Gen AI) supports with the enhancement of existing BSS functions and pr...

As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...

Industrial manufacturing faces unprecedented disruption from equipment downtime, skills shortages, and volatile trade policies, while legacy systems struggle to integrate with modern AI. Fortune 500 companies lose significant revenue each year to unplanned downtime. At the same time, manufacturers face margin compression from tariff volatility and ...

This Frost Radar™ analyzes the clinical ambient AI solutions that enable clinicians to improve their efficiency at the point of care. AI scribe capability has become the baseline market requirement, eliminating it as a differentiator and pushing vendors to compete on higher-order clinical and financial workflow integration. These capabilities inclu...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...